HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Philip A Ades Selected Research
Philip A Ades Research Topics
Disease
16
Heart Failure
11/2021 - 10/2004
12
Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2002
11
Coronary Disease (Coronary Heart Disease)
09/2016 - 02/2002
10
Weight Loss (Weight Reduction)
11/2020 - 02/2002
9
Insulin Resistance
11/2017 - 05/2003
8
Myocardial Infarction
11/2021 - 08/2003
7
Body Weight (Weight, Body)
07/2014 - 02/2002
6
Obesity
01/2021 - 05/2006
5
Hypertension (High Blood Pressure)
01/2019 - 04/2005
5
Overweight
09/2013 - 05/2006
4
Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2017 - 04/2005
4
Diabetes Mellitus
09/2016 - 05/2007
3
Neoplasms (Cancer)
01/2019 - 03/2015
3
Inflammation (Inflammations)
01/2014 - 09/2010
2
Heart Diseases (Heart Disease)
01/2019 - 01/2017
2
Muscle Weakness
08/2011 - 11/2009
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2022
1
COVID-19
01/2021
1
Weight Gain
01/2019
1
Fatigue
11/2017
1
Knee Osteoarthritis
04/2017
1
Systolic Heart Failure
01/2017
1
Acute Coronary Syndrome
01/2017
1
Type 2 Diabetes Mellitus (MODY)
09/2016
1
Myalgia
02/2016
1
Muscular Diseases (Myopathy)
02/2016
1
Atrophy
06/2015
1
Vascular Diseases (Vascular Disease)
06/2014
1
Hyperlipidemias (Hyperlipidemia)
12/2011
1
Malnutrition (Nutritional Deficiencies)
08/2010
1
Stable Angina
11/2006
1
Abdominal Obesity
04/2005
Drug/Important Bio-Agent (IBA)
8
Lipids
IBA
11/2017 - 05/2003
5
C-Reactive Protein
IBA
11/2013 - 02/2002
4
Proteins (Proteins, Gene)
FDA Link
03/2012 - 01/2006
4
HDL Cholesterol
IBA
05/2009 - 05/2003
3
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
02/2016 - 08/2008
3
Glucose (Dextrose)
FDA Link
Generic
11/2015 - 01/2004
2
Oxygen (Dioxygen)
IBA
01/2020 - 11/2008
2
Myosin Heavy Chains (Myosin Heavy Chain)
IBA
06/2015 - 01/2006
2
Myosins (Myosin)
IBA
10/2010 - 11/2009
2
Insulin (Novolin)
FDA Link
08/2010 - 05/2009
2
Triglycerides (Triacylglycerol)
IBA
05/2009 - 04/2005
1
Solutions
IBA
01/2019
1
LDL Cholesterol
IBA
06/2014
1
LDL Lipoproteins (beta Lipoproteins)
IBA
06/2014
1
Fibrinogen (Factor I)
FDA Link
11/2013
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
11/2013
1
Adenosine Diphosphate (ADP)
IBA
11/2013
1
Plasminogen Activator Inhibitor 1
IBA
11/2013
1
P-Selectin
IBA
11/2013
1
Enzymes
IBA
06/2012
1
Muscle Proteins (Muscle Protein)
IBA
08/2010
1
Amino Acids
FDA Link
08/2010
1
Plasminogen Activators (Plasminogen Activator)
IBA
05/2009
1
IS 23
IBA
05/2007
1
Interleukin-6 (Interleukin 6)
IBA
05/2006
1
Cytokines
IBA
05/2006
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
05/2006
1
Hormones (Hormone)
IBA
01/2006
1
Protein Isoforms (Isoforms)
IBA
01/2006
1
Messenger RNA (mRNA)
IBA
01/2006
1
oxidized low density lipoprotein
IBA
05/2005
1
Lipoproteins (Lipoprotein)
IBA
05/2003
1
Cholesterol
IBA
05/2002
1
N 30
IBA
02/2002
Therapy/Procedure
36
Cardiac Rehabilitation
01/2022 - 04/2002
10
Secondary Prevention
11/2019 - 04/2002
9
Resistance Training
04/2017 - 02/2002
7
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 06/2006
4
Percutaneous Coronary Intervention
11/2021 - 11/2006
4
Therapeutics
01/2019 - 03/2015
1
Stents
01/2017
1
Patient Readmission
01/2017
1
Activities of Daily Living (ADL)
08/2011
1
Tai Ji (Tai Chi Chuan)
10/2004
1
Bed Rest (Bedrest)
08/2003
1
Caloric Restriction
02/2002